Press Releases

Feb 14, 2024 6:00am EST

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Nov 21, 2023 6:00am EST

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

Dec 29, 2022 6:48am EST

Greenwich LifeSciences Provides Year End Update

Dec 01, 2022 6:00am EST

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

Aug 11, 2022 10:30am EDT

Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial

Aug 03, 2022 8:00am EDT

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

Jul 28, 2022 6:00am EDT

Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Jul 12, 2022 6:00am EDT

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

Jul 11, 2022 4:15pm EDT

Greenwich LifeSciences Announces Suspension of Share Repurchase Program

May 23, 2022 7:00am EDT

Greenwich LifeSciences to Resume Stock Repurchase Program